Human pharmacokinetics prediction with an <i>in vitro</i>–<i>in vivo</i> correction factor approach and <i>in vitro</i> drug-drug interaction profile of bictegravir, a potent integrase-strand transfer inhibitor component in approved biktarvy^® for the treatment of HIV-1 infection

Raju Subramanian, Bill J. Smith, Bernard P. Murray et al.|Xenobiotica|2022

Cited by 5